DiaSorin SpA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DiaSorin SpA (DIAS)
DiaSorin SpA stock price live, this page displays BIT DIAS stock exchange data. View the DIAS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DiaSorin SpA real time stock price chart below.
What Is the DiaSorin SpA Stock Price Today?
The DiaSorin SpA stock price today is 75.40.
What Is the Stock Symbol for DiaSorin SpA?
The stock symbol for DiaSorin SpA is "DIAS."
What Stock Exchange Does DiaSorin SpA Trade On?
DiaSorin SpA is listed and trades on the Milan stock exchange.
Is DiaSorin SpA a Good Stock to Buy?
Determining whether DiaSorin SpA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DIAS quote. (ISIN: IT0003492391)
What Is the DiaSorin SpA Stock Price Today?
The DiaSorin SpA stock price today is 75.40.
What Is the Stock Symbol for DiaSorin SpA?
The stock symbol for DiaSorin SpA is "DIAS."
What Stock Exchange Does DiaSorin SpA Trade On?
DiaSorin SpA is listed and trades on the Milan stock exchange.
Is DiaSorin SpA a Good Stock to Buy?
Determining whether DiaSorin SpA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DIAS quote. (ISIN: IT0003492391)
75.40
+0.94(+1.26%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.66
76.26
52 wk Range
52.34
92.32
DIAS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
74.6676.26
52 wk Range
52.3492.32
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DIAS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
72.45
Downside
-3.91%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
DiaSorin SpA receives Investment Bank Analyst Rating Update- Investing.com
Pro
- DiaSorin SpA receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
DiaSorin SpA receives Investment Bank Analyst Rating Update- Investing.com
Pro
DiaSorin SpA receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
5 Buy
6 Hold
3 Sell
Ratings:
14 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 72.45
(-3.91% Downside)
DiaSorin SpA Earnings Call Summary for Q2/2026
- Q2 revenue grew 4% at constant rates, rebounding from weak Q1; full-year guidance reaffirmed at 5-6% growth and 32-33% EBITDA margin.
- EBITDA margin improved to 33% in Q2 from 31% in Q1, driven by stronger revenue and operating leverage despite ongoing pricing pressures.
- QuantiFERON, LIAISON PLEX, and NES platforms showed momentum; U.S. market returned to historical growth while China declined 25%.
- Net debt rose to EUR 844M from EUR 580M in Dec 2025, pressured by inventory buildup for NES launch and EUR 3.6M share buyback program.
- Management expects H2 improvement from normalized flu season, accelerated NES placements in Q3-Q4, and PLEX European launch in Q1 2027.
Last Updated: 07/31/2026, 10:34 PM
Read Full TranscriptEarnings
Latest Release
Jul 30, 2026
EPS / Forecast
1.04 / 1.00
Revenue / Forecast
315M / 315.26M
Compare DIAS to Peers and Sector
Metrics to compare | DIAS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDIASPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.6x | 28.2x | −0.4x | |
PEG Ratio | −1.20 | −0.01 | 0.00 | |
Price/Book | 2.6x | 2.0x | 2.6x | |
Price / LTM Sales | 3.2x | 2.2x | 3.0x | |
Upside (Analyst Target) | −2.5% | 9.3% | 48.7% | |
Fair Value Upside | Unlock | 0.9% | 5.6% | Unlock |
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Diasorin (DIAS) Stock Price Today?
The Diasorin stock price today is 75.40 EUR.
What Stock Exchange Does Diasorin Trade On?
Diasorin is listed and trades on the Milan Stock Exchange.
What Is the Stock Symbol for Diasorin?
The stock symbol for Diasorin is "DIAS."
Does Diasorin Pay Dividends? What’s The Current Dividend Yield?
The Diasorin dividend yield is 1.75%.
What Is the Diasorin Market Cap?
As of today, Diasorin market cap is 3.73B EUR.
What Is Diasorin's Earnings Per Share (TTM)?
The Diasorin EPS (TTM) is 2.74.
When Is the Next Diasorin Earnings Date?
Diasorin will release its next earnings report on Nov 06, 2026.
From a Technical Analysis Perspective, Is DIAS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Diasorin Stock Split?
Diasorin has split 0 times.
How Many Employees Does Diasorin Have?
Diasorin has 3260 employees.
What is the current trading status of Diasorin (DIAS)?
As of Aug 08, 2026, Diasorin (DIAS) is trading at a price of 75.40 EUR, with a previous close of 74.46 EUR. The stock has fluctuated within a day range of 74.66 EUR to 76.26 EUR, while its 52-week range spans from 52.34 EUR to 92.32 EUR.
What Is Diasorin (DIAS) Price Target According to Analysts?
The average 12-month price target for Diasorin is 72.45 EUR, with a high estimate of 90 EUR and a low estimate of 58 EUR. 5 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Neutral. The stock has an -3.91% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.